Creating AI to simulate biology and improve the lives of patients

Science First

Unlearn was founded by scientists, who wanted to find a new, evidence-based approach. We operate based on proprietary approaches to machine learning principles and regulatory guidances.

A Culture of Precision

Statistical rigor and clinical excellence drive us. We are impacting patient lives, and we hold ourselves to the highest standards.

Trusted Innovator

We are working diligently towards validated innovation. We ensure our products address our customers' exact needs while mitigating risk.

Culture and team

Unlearn was started to solve hard problems. We foster an environment and culture that empowers everyone to do their best work, so we can find solutions together.
Strategic Advisor

Craig H. Lipset

Scientific Advisor

Collin Stultz

Scientific Advisor

Pankaj Mehta

Regulatory Advisor

Marina Brodsky

Regulatory Advisor

Diane Shoda

Strategic Advisor

Daniel Omura

Strategic Advisor

Cami Clark

No items found.
Founder & CEO

Charles K. Fisher

Chief Commercial Officer

Julia Coelho

Chief Operating Officer

Graham Siegel

Founder

Aaron Smith

Founder

Jon Walsh

Machine Learning Scientist

Anton Loukianov

Software Engineer

Brian Wai

Machine Learning Scientist

David Li-Bland

Software Engineer

Juan Arrivillaga

Data Scientist

Alejandro Schuler

Data Scientist

Daniele Bertolini

Data Scientist

Diana Hall

Sr. Computational Biologist

Yannick Pouliot

Clinical Product Manager

Cole Roberts

Marketing Manager

Dana Jasek

Office Manager

Kelsea Jordan

No items found.
No items found.
No items found.
No items found.
No items found.
Podcasts

Your Digital Twin - UnlearnAI

A fascinating approach to the problem of how to make clinical trials more efficient, and understand more about what may be possible with more and better patient data.
Press

Unlearn.AI nabs $12M to build “Digital Twins” to speed up and improve clinical trials

“Unlearn’s pioneering use of Digital Twins will limit the number of patients that need to go on placebo while also reducing overall trial enrollment time."
Press

Will digital clones transform how pharmas run clinical trials? This S.F. startup is counting on it.

The San Francisco-based company creates digital replicas of participants in clinical drug trials using artificial intelligence. The result, says Charles Fisher...

Job Openings

Transform clinical research with us

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.